Onchocerciasis control: Impressive achievements not to be wasted

Canadian Journal of Ophthalmology

Volumn 42, Issue 1, 2007, Pages 13-15

  Hopkins, Adrian D ^a  

^a Ophthalmology Training Centre for Central Africa   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLCARBAMAZINE; IVERMECTIN; MOXIDECTIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; COMMUNITY CARE; DISEASE CONTROL; DISEASE TRANSMISSION; DRUG INDUSTRY; EDITORIAL; ENDEMIC DISEASE; FILARIASIS; GOVERNMENT; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ONCHOCERCIASIS; PUBLIC HEALTH SERVICE; TROPICAL DISEASE; TUBERCULOSIS; VISUAL IMPAIRMENT;

EID: 33947132229     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1139/I06-105     Document Type: Editorial

References (21)

1. Hissette J. Mémoire sur «Leuckart» et ses manifestations oculaires au Congo Belge. Ann Soc Belge Med Trop 1932;12: 443-529.
2. World Health Organisation. Success in Africa: the Onchocerciasis Control Programme in West Africa 1974-2002. World Health Organ Tech Rep Ser 2002; 885: 1-72.
3. Peters DH, Philips T. Mectizan donation program: evaluation of a public-private partnership. Trop Med Int Health 2004;9(Suppl):A4-A15.
4. Drameh PS, Richards FO, Cross C, Etya'ale DE, Kassalow JS. Ten years of NGDO action against river blindness. Trends Parasitol 2002;18:378-80.
5. Ngoumou P, Walsh JF. A Manual for Rapid Epidemiological Mapping of Onchocerciasis. TDR/TDE/ONCHO/93.4. Geneva: WHO; 1993.
6. Community Directed Treatment with Ivermectin (CDTI). A Practical Guide for Trainers of Community Directed Distributors. Ouagadougou: APOC; 1998.
7. The challenges of community-directed treatment with ivermectin (CDTI) within the African Programme for Onchocerciasis Control (APOC) Ann Trop Med Parsitol 2002;96(suppl 1):S41-S58.
8. Molyneux DH, Nantulya VM. Linking disease control programmes in rural Africa a pro-poor strategy to reach Abuja targets and millennium development goals BMJ 2004;328:1129-32.
9. Homeida M, Braide E, ElHassan E, et al. APOC's strategy of community-directed treatment with ivermectin (CDTI) and its potential for providing additional health services to the poorest populations. Ann Trop Med Parsitol 2002;96(suppl 1):S93-S104.
10. Hotez PJ, Molyneux DH, Fenwick A, Ottesen E, Erlich Sachs S, Sachs JD. Incorporating a rapid-impact package for neglected tropical diseases with programmes for HIV/AIDs, tuberculosis, and malaria. A comprehensive pro-poor health policy and strategy for the developing world. PLOS Med 2006;3:e102.
11. Amazigo UV, Obono OM, Dadzie KY. Monitoring community directed treatment programmes for sustainability: lessons from the African Programme for Onchocercaisis Control (APOC). Ann Trop Med Parsitol 2002a;96(suppl 1):S75-S92.
12. World Health Organisation. Onchocerciasis (river blindness) Report of the fifteenth Inter American Conference on Onchocerciasis, Caracas Venezuela. Wkly Epidemiol Rec 2006; 81:293-6.
13. Hopkins AD. Ivermectin and Onchocerciasis: is it all solved? Eye 2005;19:1057-66.
14. Homeida MMA, Goeppl Ali M, Hilyer E, Mackenzie CD. Medical achievements under civil war conditions Lancet 1999;354:601.
15. Hopkins AD. Distribution d'ivermectine dans les pays en conflit. Cahiers Santé 1998;8:72-4.
16. Dadzie Y, Neira M, Hopkins D. Final report on the eradicability of Onchocerciasis. Filaria J 2003;2:2. Available: http://www.filariajournal. com/content/2/1/2 (accessed 2006 Nov 26).
17. Kennedy MH, Bertocchi I, Hopkins AD, Meredith SE. The effect of 5 years of annual treatment with ivermectin (Mectizan) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic. Ann Trop Med Parsitol 2002;96:297-307.
18. Emukah EC, Osuoha E, Miri ES, et al. A longitudinal study of impact of repeated mass ivermectin treatment on clinical manifestations of onchocerciasis in Imo State, Nigeria. Am J Trop Med Hyg 2004;70:556-61.
19. Pion SDS, Clément MCA, Boussinesq M. Impact of four years large scale ivermectin treatment with low therapeutic coverage of Onchocerca volvulus in the Mbam valley focus, central Cameroun. Trans R Soc Trop Med Hyg 2004;98: 520-8.
20. Gardon J, Boussinesq M, Kamgno J, Gardon-Wendel N, Demanga-Ngangue N, Duke BOL, Effects of standard and high doses of ivermectine on adult worms of Onchocerca volvulus: a randomised controlled trial. Lancet 2002;360: 203-10.
21. Kamgno J, Gardon J, Gardon-Wendel N, Demanga-Ngangue N, Duke BOL, Boussinesq M. Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three monthly. Trans R Soc Trop Med Hyg 2004;98:496-505.